Thrombosis is the #1 cause of death and debilitation. It is initiated by the blood activities related to inflammaging, a key contributor to inflammation and aging. Aimorphous Health develops blood diagnostics that delivers monitoring of blood activities leading to thrombosis, inflammation and aging. By utilizing AI and breakthrough blood biomarkers, the device mediates the monitoring of cryptic biological activities so that people can be informed of their inflammaging activity, have better cardiovascular and general health, and achieve longevity through evidence-based health monitoring. It aims to reduce massively the mortality and the lost of quality live due to inflammaging and thrombosis.
29.11.2024
Global recognition for Swiss innovations (startupticker.ch)
29.09.2023
Quatre nouvelles startups pour le troisième DayOne Tech (startupticker.ch)
No milestones
No Jobs
Aimorphous' media
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.aimorphous.health
Headquarter:
Courroux
Foundation Date:
July 2022
Technology:
Sectors: